Melatonin: A potential nighttime guardian against Alzheimer's.

Mol Psychiatry · 2025 · PMC11649572 · PMID 39128995

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

In the transgenic AD mouse model Tg2576, marked by mutant APP overexpression in the brain, melatonin treatment exhibited a trend of elevated Aβ levels in cervical and axillary lymph nodes, concomitant with a decreasing trend in brain Aβ [ 76 ].

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.